HF
MNPR icon

HRT Financial’s Monopar Therapeutics MNPR Stock Holding History

HRT Financial’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,228
Closed -$299K – 3212
2025
Q1 		$299K Buy
+8,228
New +$296K ﹤0.01% 1778
2024
Q2 		– Sell
-6,423
Closed -$21K – 2754
2024
Q1 		$21K Buy
+6,423
New +$19.1K ﹤0.01% 2011
2023
Q4 		– Sell
-2,616
Closed -$7K – 2794
2023
Q3 		$7K Buy
+2,616
New +$9.14K ﹤0.01% 2154

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's MNPR Position: Q2 2025 in Review

HRT Financial sold out of Monopar Therapeutics (MNPR) in Q2 2025, closing a stake of 8,228 shares — an estimated $299K sold.

HRT Financial first reported a position in MNPR in Q3 2023 and held it in 3 quarters. The position peaked at $299K in Q1 2025. 43 funds tracked by Wall St. Rank hold MNPR as of Q2 2025.

  • HRT Financial reported no remaining Monopar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 8,228 Monopar Therapeutics shares in Q2 2025, an estimated $299K.
  • HRT Financial first reported a position in Monopar Therapeutics in Q3 2023 and held it in 3 quarters.
  • HRT Financial's Monopar Therapeutics position peaked at $299K in Q1 2025.
  • 43 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.